UPDATE: Amedisys (AMED) Reports In-Line EPS, Revenue Tops Views; CFO to Retire

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to UPDATE: Amedisys (AMED) Reports In-Line EPS, Revenue Tops Views; CFO to Retire

Mizuho Securities Downgrades Amedisys (AMED) Neutral, PT Cut to $55

August 3, 2016 7:06 AM EDT

Mizuho Securities downgraded Amedisys (NASDAQ: AMED) from Buy to Neutral and cut the price target to $55.00 (from $57.00), following the company's 2Q earnings report. Management pointed out that it had underestimated the HCHB disruption costs previously and is working to correct that. As a... More